Seelos Therapeutics Inc (NASDAQ:SEEL)
| 1.65 Delayed Data As of Dec 08 |  -0.04 / -2.37%Today’s Change | 1.04 Today|||52-Week Range 49.80 | -91.90% Year-to-Date |
Latest SEEL News | Press Releases
No recent news for Seelos Therapeutics Inc.
Today’s Trading
| Previous close | 1.69 |
| Today’s open | 1.69 |
| Day’s range | 1.64 - 1.71 |
| Volume | 19,019 |
| Average volume (3 months) | 405,994 |
| Market cap | $7.8M |
Data as of 3:58pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | +4.84% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Financials
| Next reporting date | March 1, 2024 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$73.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
